Sun Pharma: Leading the Bull Run Sun Pharma continues to surge with strong earnings, expanding global footprint, and robust demand for specialty and chronic therapies.
Dr. Reddy’s Laboratories: Consistent Performer Dr. Reddy’s gains traction with steady U.S. market growth, strong generics portfolio, and focused R&D pipeline for new launches.
Cipla: Innovation Driving Growth Cipla shines with increased exports, respiratory medicine leadership, and continued investments in biotech and digital healthcare innovations.
Lupin: Recovery and Expansion Lupin’s recent regulatory approvals and focus on niche formulations are boosting investor confidence and driving steady upward momentum.
Aurobindo Pharma: Global Growth Story Aurobindo Pharma’s strong international sales and diversification into biosimilars and injectables make it a stock to watch in 2025.